Effects of maternal serum on permeability of glomerular endothelial cell membrane

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 1, 2011, Pages 17-20

  Du, Hui ^a   Liu, Haiyi ^a   Zhao, Jun ^a   Wu, Yuanyuan ^a   Gong, Xun ^a   Zhou, Qiong ^a   Xu, Jingjing ^a   Li, Yuqi ^a   Shi, Xinwei ^a   Qiao, Fuyuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

glomerular endothelial cells; permeability; preeclampsia; serum; sFlt 1; VEGF

Indexed keywords

FLT1 PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD; CELL MEMBRANE PERMEABILITY; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; GLOMERULUS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY;

ADULT; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; FEMALE; HUMANS; KIDNEY GLOMERULUS; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79952760697     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0143-7     Document Type: Article

References (25)

1. B. Sibai G. Dekker M. Kupferminc, et al. 2005 Preeclampsia Lancet 365 9461 785 799 15733721
2. S. Lorquet C. Pequeux C. Munaut, et al. 2010 Aetiology and physiopathology of preeclampsia and related forms Acta Clin Belg 65 4 237 241 1:STN:280:DC%2BC3cbgtlSgtA%3D%3D 20954461
3. J. Myers G. Mires M. Macleod, et al. 2005 In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease Hypertension 45 2 258 263 1:CAS:528:DC%2BD2MXmtVWntA%3D%3D 10.1161/01.HYP.0000153461.58298.a4 15630046 (Pubitemid 40179969)
4. B.D. LaMarca J. Gilbert J.P. Granger, et al. 2008 Recent progress toward the Understanding of the pathophysiology of hypertension during preeclampsia Hypertension 51 4 982 988 1:CAS:528:DC%2BD1cXjt1ektrk%3D 10.1161/ HYPERTENSIONAHA.107.108837 18259004 (Pubitemid 351398991)
5. A.M. Germain M.C. Romanik I. Guerra, et al. 2007 Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49 1 90 95 1:CAS:528:DC%2BD28XhtlSrs7jJ 10.1161/01.HYP.0000251522.18094.d4 17116761 (Pubitemid 46360346)
6. I.E. Stillman S.A. Karumanchi 2007 The glomerular injury of preeclampsia J Am Soc Nephrol 18 8 2281 2284 10.1681/ASN.2007020255 17634433 (Pubitemid 47203843)
7. W.M. Deen 2004 What determines glomerular capillary permeability? J Clin Invest 114 10 1412 1414 1:CAS:528:DC%2BD2cXpvFOqsL8%3D 15545991 (Pubitemid 40385571)
8. V. Tsatsaris F. Goffin C. Munaut, et al. 2003 Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endo Meta 88 11 5555 5563 1:CAS:528:DC%2BD3sXptVyntLc%3D 10.1210/jc.2003-030528 (Pubitemid 37452769)
9. S.E. Maynard J.Y. Min S.A. Karumanchi, et al. 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 649 658 1:CAS:528:DC%2BD3sXhvFentbc%3D 12618519 (Pubitemid 36278583)
10. S. Yelumalai S. Muniandy S.Z. Omar, et al. 2010 Pregnancyinduced hypertension and preeclampsia: Levels of angiogenic factors in Malaysian women J Clin Biochem Nutr 47 3 191 197 1:CAS:528:DC%2BC3MXhvVGhs7o%3D 10.3164/jcbn.10-27 21103027
11. K. Asanuma E. Yanagida-Asanuma M. Takagi, et al. 2007 The role of podocytes in proteinuria Nephrology (Carlton) 12 3 15 20 10.1111/j.1440-1797. 2007.00876.x (Pubitemid 350077387)
12. J. Patrakka K. Tryggvason 2009 New insights into the role of podocytes in proteinuria Nat Rev Nephrol 5 8 463 468 1:CAS:528:DC%2BD1MXpsVKgsLg%3D 10.1038/nrneph.2009.108 19581907
13. V.D. Garovic S.J. Wagner L.M. Petrovic, et al. 2007 Glumerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia Nephrol Dial Transplant 22 4 1136 1143 1:CAS:528:DC%2BD2sXjslOgtLg%3D 10.1093/ndt/gfl711 17255128 (Pubitemid 46523429)
14. F. Collino B. Bussolati E. Gerbaudo, et al. 2008 Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells Am J Physiol Renal Physiol 294 5 1185 1194 10.1152/ajprenal. 00442.2007
15. S.C. Satchell C.H. Tasman A. Singh, et al. 2006 Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF Kidney Int 69 9 1633 1640 1:CAS:528:DC%2BD28XjvF2ksrw%3D 10.1038/sj.ki.5000277 16557232
16. P.A. van Setten V.W. van Hinsbergh T.J. van der Velden, et al. 1997 Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells Kidney Int 51 4 1245 1256 10.1038/ki.1997.170 9083293 (Pubitemid 27186553)
17. M. Shibuya 2001 Structure and dual function of vascular endothelial growth factor receptor-1(Flt-1) Int J Biochem Cell Bio 3 4 409 420 10.1016/S1357-2725(01)00026-7 (Pubitemid 32328114)
18. R.J. Levine S.E. Maynard C. Qian, et al. 2004 Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 672 683 1:CAS:528:DC%2BD2cXhtFCrt7w%3D 10.1056/NEJMoa031884 14764923 (Pubitemid 38364626)
19. R.W. Powers J.M. Roberts K.M. Cooper, et al. 2005 Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia Am J Obstet Gynecol 193 1 185 191 1:CAS:528:DC%2BD2MXmtFSntLo%3D 10.1016/j.ajog.2004. 11.038 16021077 (Pubitemid 40991843)
20. H. Nakatsukasa H. Masuyama N. Takamoto, et al. 2008 Circulating leptin and angiogenic factors in preeclampsia patients Endocr J 55 3 565 573 1:CAS:528:DC%2BD1cXhtVOntrvF 10.1507/endocrj.K07E-136 18490835 (Pubitemid 351949754)
21. S.A. Karumanchi M.D. Lindheimer 2008 Advances in the understanding of eclampsia Curr Hypertens Rep 10 4 305 312 10.1007/s11906-008-0057-3 18625161
22. S. Ahmad A. Ahmed 2005 Antiangiogenic effect of soluble vascular endothelial growth factor receptor-l in placental angiogenesis Endothelium 12 1-2 89 95 1:CAS:528:DC%2BD2MXks1Ontrk%3D 10.1080/10623320590933888 16036320 (Pubitemid 40861891)
23. D.H. Kang R.J. Johnson 2003 Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis Curr Opin Nephrol Hypertens 12 1 43 49 1:CAS:528:DC%2BD2cXps1Cg 10.1097/00041552-200301000-00008 12496665 (Pubitemid 36092314)
24. L. Fan T. Wakayama S. Yokoyama, et al. 2002 Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis Nephron 90 1 95 102 1:CAS:528:DC%2BD3MXptFClt70%3D 10.1159/000046320 11744811 (Pubitemid 34042847)
25. D.H. Kang J. Hughes M. Mazzali, et al. 2001 Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor Administration reduces renal fibrosis and stabilizes renal function J Am Soc Nephrol 12 7 1448 1457 1:CAS:528:DC%2BD3MXltlSiu7s%3D 11423573 (Pubitemid 32666327)